---
schema_version: "secwatch.filing_event.v1"
accession: "0001823239-22-000048"
form_type: "8-K"
ticker: "MRVI"
cik: "0001823239"
company_name: "MARAVAI LIFESCIENCES HOLDINGS, INC."
filed_at: "2022-10-03T23:59:59+00:00"
generated_at: "2026-06-23T06:06:01.082895+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Maravai names Trey Martin CEO, co-founder Carl Hull becomes Executive Chairman

## Summary
- Martin appointed CEO effective Sept 30, 2022, succeeding Carl Hull who becomes Executive Chairman.
- Martin previously SVP at Danaher, President of Integrated DNA Technologies; over 25 yrs in life sciences.
- Martin receives base salary $750k, target bonus $937.5k for 2022, and equity awards totaling ~$17M.
- Hull's base salary reduced to $500k; target bonus for 2022 remains $725k, subsequent years 100% of base.
- Company to discuss transition on Q3 2022 earnings call scheduled for Nov 2.

## SEC filing metadata
- accession: 0001823239-22-000048
- form_type: 8-K
- ticker: MRVI
- cik: 0001823239
- company_name: MARAVAI LIFESCIENCES HOLDINGS, INC.
- filed_at: 2022-10-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1823239/000182323922000048/0001823239-22-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1823239/000182323922000048/mrvi-20220930.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001823239-22-000048
- JSON: https://secwatch.observer/filing/0001823239-22-000048.json
- Plain text: https://secwatch.observer/filing/0001823239-22-000048.txt

## Key facts
- Executive change
  William "Trey" Martin, III was appointed as Chief Executive Officer at MARAVAI LIFESCIENCES HOLDINGS, INC..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: On September 30, 2022, William “Trey” Martin, III was appointed Chief Executive Officer of Maravai LifeSciences Holdings, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1823239/000182323922000048/0001823239-22-000048-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.